Photocure, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment. The Company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Visonac that has completed Phase IIb study for the treatment of moderate to severe acne; and Cevira, which has completed Phase IIb study for the treatment of human papilloma virus infection and precancerous lesions of the cervix.